Risk Factors Affecting Complications Due to Prostate Biopsy
Journal Title: The Bulletin of Urooncology - Year 2019, Vol 18, Issue 2
Abstract
Objective: Currently, transrectal ultrasound (TRUS) guided prostate biopsy is the standard method used for prostate cancer detection. In the last decade, hospitalization due to complications has increased, especially due to infectious causes. Therefore, it is important to determine the risk factors affecting the complications of prostate biopsy. Materials and Methods: One hundred and sixty-four patients who underwent TRUS-guided prostate biopsy due to prostate cancer suspicion were included in our study. Patients’ ages, total and free prostate specific antigen (PSA) levels, prostate volumes, digital rectal examination findings, level of education, pathology results and pain related to the procedure were recorded. A 10-cm long visual analogue scale (VAS) was used to assess the pain of the patients. Complications related to the procedure were questioned firstly on the same day and secondly during the visit of the patient for pathology. As a result of these evaluations, complications divided into three groups as none, minor (no intervention) and major (medically or surgically treated). Results: In our study, minor complications included rectal bleeding in 42 patients and hematuria lasting longer than 48 hours in 11 patients. Major complications were fever of >38 °C in two patients and epididymitis in one patient. There was no statistically significant effect of age, total and free PSA, prostate volume, level of education, digital rectal examination findings and pathology results on complications. There was no statistically significant relationship between VAS pain score and rectal bleeding, hematuria, epididymitis. On the other hand, a statistically significant relationship was found between VAS pain score and fever. Conclusion: In the limited number of studies on the determination of risk factors for complications associated with prostate biopsy, the level of education, digital rectal examination findings, and pain due to the procedure were evaluated. In the light of our results, we believe that patients with high pain scores may be at risk for complications, especially for fever.
Authors and Affiliations
Sinan Avcı, Sedat Öner, Efe Önen, Volkan Çağlayan, Metin Kılıç, Murat Şambel
Keywords
Related Articles
- EP ID EP48737
- DOI 10.4274/uob.galenos.2018.1149
- Views 253
- Downloads 0
Evaluation of General Features of Patients with Testicular Cancer
Objective: Testicular cancers (Tca) are most common in men aged 20-34. Despite the increase in its incidence, the mortality rate from Tca decreases. In our study, it was aimed to evaluate the general characteristics, the...
Relationship Between AMACR Staining Density of Radical Prostatectomy Specimen and Biochemical Recurrence in Patients with Pathological Stage T2a-b
Objective: This study aimed to evaluate the relationship between Alpha-methylacyl-CoA racemase (AMACR) staining intensity of pathologic specimens and Prostate Spesific Antigen (PSA) recurrence of patients with an organ-l...
Non-muscle Invasive Bladder Cancer: Identifying Patients to Consider Timely, Initial Cystectomy
Non-muscle invasive bladder cancer is a heterogeneous disease with widely varying risks of recurrence and progression to muscle invasion. Risk stratification within current treatment guidelines are an attempt to address...
Acute Ischemic Stroke Following Chemotherapy for Malignant Mixed Testicular Germ Cell Tumour: Does Cisplatin Play a Role?
Among males aged between 15 and 35 years, testicular cancer is the most commonly diagnosed cancer. Testicular germ cell tumours are generally considered curable and respond dramatically to adjuvant treatment. Cisplatin-b...
Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey
Objective: The aim of this study is to investigate the relevance of the Epstein criteria for the 12-core transrectal prostate biopsy (TRUS-Bx) scheme with the evaluation of clinicopathologic data recorded in the Urologic...